NASDAQ cannabis player FLGC teams up with leader Canopy Growth in epic distribution agreement.

Flora Growth Corp. Enters $94 million Australian Medical Cannabis Market with Recognized Giant Canopy Growth Corp. in a Distribution Agreement for Storz & Bickel Vaporizers!

According to Grand View Research, the Australia medical cannabis market size was estimated at $94 million and is projected to grow at a CAGR of 33.6% from 2024 to 2030. According to Transparency Market Research, the global handheld marijuana vaporizer market is approximately $5 billion and is anticipated to grow at a 13.4% CAGR and by 2031. 

This all shines a light on Flora Growth Corp. (NASDAQ: FLGC), a small cap emerging legal cannabis company that just announced a distribution agreement with Canopy Growth Corp. for the distribution of Canopy's Storz & Bickel ("Storz") medical line of vaporizers in Australia through Flora's subsidiary, Australian Vaporizers. This is a remarkable milestone for FLGC as Canopy Growth is a market leader with a $400 million market capitalization! With this agreement FLGC will benefit from Canopy Growth's well-established global reputation and expertise in the medical cannabis sector.

Australian Vaporizers, Flora Growth Corp. (NASDAQ: FLGC)’s subsidiary in the Australian market, will spearhead the distribution of Storz vaporizers to healthcare professionals, and clinics across the country. Known for its comprehensive range of high-quality vaporization products, Australian Vaporizers has established itself as a trusted name within the country's medical cannabis ecosystem.  And this is just one of FLGC’s many lucrative divisions. The company manufactures and distributes consumer packaged goods, medicinal cannabis and pharmaceutical products in all 50 states and 28 countries with 20,000+ points of distribution around the world. FLGC’s goal is to become the leading NASDAQ small cap international cannabis company. 

Discover more about FLGC and why ROTH MKM has a “BUY” rating and a $6.00 price target on the stock!